Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I

BACKGROUND: Exosome administration is a novel medical approach that promises excellent immunomodulatory properties without the conventional side effects of current antitumor necrosis factor drugs and stem cells. This study aimed to assess the safety and efficacy of using mesenchymal stem cell (MSC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazari, Hojjatollah, Alborzi, Foroogh, Heirani-Tabasi, Asieh, Hadizadeh, Alireza, Asbagh, Reza Akbari, Behboudi, Behnam, Fazeli, Mohammad Sadegh, Rahimi, Mojgan, Keramati, Mohammad Reza, Keshvari, Amir, Kazemeini, Alireza, Soleimani, Masoud, Ahmadi Tafti, Seyed Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733972/
https://www.ncbi.nlm.nih.gov/pubmed/36518984
http://dx.doi.org/10.1093/gastro/goac075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733972/
https://www.ncbi.nlm.nih.gov/pubmed/36518984
http://dx.doi.org/10.1093/gastro/goac075

Ejemplares similares